Imunon (IMNN) Deferred Taxes (2013 - 2024)
Imunon's (IMNN) quarterly Deferred Taxes came in at $1.3 million in Q1 2024, down 18.29% YoY from $1.6 million in Q2 2023, and up 200.0% on a QoQ basis from -$1.3 million in Q4 2023.
Imunon (IMNN) Deferred Taxes (2013 - 2024) Analysis & Trends
Imunon (IMNN) has 11 years of Deferred Taxes data on file, last reported at $1.3 million in Q1 2024.
- Quarterly Deferred Taxes fell 18.29% year-over-year to $1.3 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $1.3 million (up 346.69% YoY) and the FY2024 annual result came in at $1.3 million, up 346.69% from the prior year.
- Deferred Taxes rose to $1.3 million in Q1 2024, from -$1.3 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $1.8 million in Q1 2021 to a low of -$1.8 million in Q4 2020.
- A 5-year average of $202147.1 and a median of $1.3 million in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2021 — Deferred Taxes climbed 25.05% — and 2022, when it decreased 25.05%.
- Tracing IMNN's Deferred Taxes over 5 years: stood at -$1.8 million in 2020, then rose by 25.05% to -$1.4 million in 2021, then declined by 13.27% to -$1.6 million in 2022, then gained by 18.29% to -$1.3 million in 2023, then surged by 200.0% to $1.3 million in 2024.
- The last three Deferred Taxes figures came in at $1.3 million (Q1 2024), -$1.3 million (Q4 2023), and $1.6 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Imunon | 8.50 Mn | 8.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | -1.28 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | -1.57 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Mar 31, 2021 | 1.85 Mn |
| Dec 31, 2020 | -1.85 Mn |
| Mar 31, 2020 | 1.82 Mn |
| Dec 31, 2018 | -2,423.00 |
| Sep 30, 2018 | -3,054.00 |
| Jun 30, 2018 | -1,477.00 |
| Mar 31, 2018 | -1,478.00 |
| Dec 31, 2017 | -1,970.00 |
| Sep 30, 2017 | 36,840.00 |
| Jun 30, 2017 | 33,752.00 |
| Mar 31, 2017 | -9,264.00 |
| Dec 31, 2016 | -9,264.00 |
| Sep 30, 2016 | -9,265.00 |
| Jun 30, 2016 | -7,903.00 |